MEREO BIOPHARMA GROUP PLC (MREO) Operating income 2022–2025
MEREO BIOPHARMA GROUP PLC (MREO) annual operating income history from SEC filings — each fiscal year as reported.
-$40.1MFY2025 · since FY2022: -$54.4M → -$40.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$40.1M | +15.3% |
| FY2024 | -$47.4M | -66.7% |
| FY2023 | -$28.4M | +47.8% |
| FY2022 | -$54.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice